ARMRA Colostrum

Case Name (Date)

Petros et al. v. Rahal Biosciences, Inc.
24-cv-3182, S.D.N.Y.
(April 2024)

Product/Service

ARMRA Colostrum dietary supplements

Allegations

Falsely marketing products as “research-backed” to provide various health benefits – including “strengthen[ing] immunity,” “fortify[ing] gut health,” and “activat[ing] hair growth” – without adequate scientific evidence to support such claims

Failing to include mandated disclaimers with disease treatment claims, in violation of FDA regulations

Status

Voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled.